Basic Information
Hygeia Capital is a boutique venture capital firm dedicated to the healthcare sector, with a management team that has extensive background in the healthcare industry and experience in equity investment. Its investment portfolio includes high-quality companies such as Kangdelai Medical (1501.HK) (interventional medical devices), Cofoe Medical (home-use medical devices), Bestudy (clinical CRO), Zhongyi Anke (vaccine development), Vibe Biologics (new drug development), Zed Bio (protein engineering), Respicare (inhalation formulation R&D), Haibowei Pharma (new drug development), Carefix Pharma (new drug development), and Shengsi Biologics (new drug development).